# Gain Therapeutics, Inc.: Form 8-K, filed Oct 14, 2025

- Company: [Gain Therapeutics, Inc.](/companies/ganx.md) (CIK 1819411)
- Form: 8-K
- Filed: 2025-10-14
- Accepted by EDGAR: Oct 14, 2025, 16:56 ET
- Period: 2025-10-14
- Accession: 0001104659-25-099343
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819411/000110465925099343/tm2528732d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819411/000110465925099343/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819411/000110465925099343/tm2528732d1_8k.htm

Filed Oct 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-099343. Last ingested by Listed: Oct 30, 2026, 17:20 ET. No prices; not investment advice.